tiprankstipranks
Xbrane Biopharma AB (DE:7XB)
:7XB
Germany Market
Holding DE:7XB?
Track your performance easily

Xbrane Biopharma AB (7XB) Income Statement

2 Followers

Xbrane Biopharma AB Income Statement

Last quarter (Q4 2022), Xbrane Biopharma AB's total revenue was $20.86M, an increase of 80.89% from the same quarter last year. In Q4, Xbrane Biopharma AB's net income was $-60.73M. See Xbrane Biopharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 57.62M$ 57.62M$ 11.53M$ 7.09M$ 600.00K$ 112.95M
Cost of Revenue
-$ 0.00$ 0.00$ 0.00$ 18.27M$ 15.91M
Gross Profit
$ 57.62M$ 57.62M$ 11.53M$ 7.09M$ -17.67M$ 97.05M
Operating Expense
$ 210.27M$ 210.27M$ 191.93M$ 223.74M$ 162.24M$ 107.52M
Operating Income
$ -152.65M$ -152.65M$ -180.40M$ -216.65M$ -179.91M$ -10.47M
Net Non Operating Interest Income Expense
$ -2.30M$ -2.29M$ -2.64M$ -691.00K$ -1.42M$ -1.70M
Other Income Expense
$ ―$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ -168.51M$ -168.51M$ -183.23M$ -218.13M$ -187.99M$ -13.12M
Tax Provision
-$ 0.00$ 0.00$ 0.00$ 0.00$ 121.00K
Earnings From Equity Interest Net Of Tax
$ ―$ ―$ ―$ ―$ ―$ ―
Net Income Common Stockholders
$ -172.51M$ -172.51M$ -188.38M$ -226.03M$ -187.99M$ -13.24M
Basic EPS
$ -6.82$ -6.75$ -7.98$ -12.48$ -14.84$ -2.02
Diluted EPS
$ -6.82$ -6.75$ -7.98$ -12.48$ -14.84$ -2.02
Basic Average Shares
$ 102.21M$ 25.57M$ 23.59M$ 18.11M$ 11.19M$ 6.55M
Diluted Average Shares
$ 102.21M$ 25.57M$ 23.59M$ 18.11M$ 11.19M$ 6.55M
Dividend Per Share
$ ―$ ―$ ―$ ―$ ―$ ―
Total Operating Income As Reported
$ ―$ ―$ ―$ ―$ ―$ ―
Reported Normalized Basic E P S
$ ―$ ―$ ―$ ―$ ―$ ―
Reported Normalized Diluted E P S
$ ―$ ―$ ―$ ―$ ―$ ―
Rent Expense Supplemental
$ ―$ ―$ ―$ ―$ ―$ ―
Total Expenses
$ 210.27M$ 210.27M$ 191.93M$ 223.74M$ 180.51M$ 123.42M
Net Income From Continuing And Discontinued Operation
$ -172.51M$ -172.51M$ -188.38M$ -226.03M$ -187.99M$ -13.24M
Normalized Income
$ -168.51M$ -168.51M$ -183.23M$ -218.13M$ -188.01M$ -12.55M
Interest Expense
$ 2.58M$ 2.58M$ 2.64M$ 691.00K$ 1.46M$ 1.75M
EBIT
$ -165.93M$ -165.93M$ -180.59M$ -217.44M$ -186.53M$ -11.37M
EBITDA
$ -165.93M$ -165.93M$ -167.59M$ -210.87M$ -179.21M$ -7.05M
Currency in USD

Xbrane Biopharma AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis